This supports the clinical observations that large doses of insulin may be needed to achieve pregnancy glucose targets in women with GCK-MODY and those who reach pregnancy glucose targets frequently report autonomic symptoms of hypoglycemia [personal communications ATH & MH Shepherd]. This evidence concerns the gene INS and MODY.